Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BHC Bausch Health Companies Inc
- Stocks
- Healthcare
- NYSE: BHC
Price (delayed)
$4.59
Market cap
$1.7B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.11
Enterprise value
$22.05B
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of
Highlights
BHC's EPS has surged by 91% year-on-year and by 15% since the previous quarter
The net income has soared by 91% YoY and by 13% from the previous quarter
The company's equity rose by 8% QoQ but it fell by 6% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.bauschhealth.com
Key stats
What are the main financial stats of BHC
Market
Valuations
Earnings
Shares outstanding
369.55M
Market cap
$1.7B
Enterprise value
$22.05B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.17
EV/EBIT
13.84
EV/EBITDA
7.75
EV/Sales
2.27
Revenue
$9.73B
Gross profit
$6.89B
Operating income
$1.54B
Net income
-$40M
EBIT
$1.59B
EBITDA
$2.85B
Free cash flow
$1.22B
Per share
Balance sheet
Liquidity
EPS
-$0.11
EPS diluted
-$0.11
Free cash flow per share
$3.29
Book value per share
-$3.22
Revenue per share
$26.33
TBVPS
$26.98
Total assets
$26.42B
Total liabilities
$26.66B
Debt
$21.51B
Equity
-$1.18B
Working capital
$1.48B
Debt to equity
-18.18
Current ratio
1.35
Quick ratio
0.76
Net debt/EBITDA
7.15
Margins
Efficiency
Dividend
EBITDA margin
29.2%
Gross margin
70.8%
Net margin
-0.4%
Operating margin
15.8%
Return on assets
-0.2%
Return on equity
N/A
Return on invested capital
6.3%
Return on capital employed
7.2%
Return on sales
16.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BHC stock price
How has the Bausch Health Companies stock price performed over time
Intraday
-2.34%
1 week
-15.31%
1 month
-8.57%
1 year
-33.96%
YTD
-43.05%
QTD
-29.06%
Financial performance
How have Bausch Health Companies's revenue and profit performed over time
Revenue
$9.73B
Gross profit
$6.89B
Operating income
$1.54B
Net income
-$40M
Gross margin
70.8%
Net margin
-0.4%
The net margin has surged by 92% year-on-year and by 20% since the previous quarter
The net income has soared by 91% YoY and by 13% from the previous quarter
The company's operating income rose by 44% YoY
The operating margin has grown by 33% YoY
Price vs fundamentals
How does BHC's price correlate with its fundamentals
Growth
What is Bausch Health Companies's growth rate over time
Valuation
What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.17
EV/EBIT
13.84
EV/EBITDA
7.75
EV/Sales
2.27
BHC's EPS has surged by 91% year-on-year and by 15% since the previous quarter
The company's equity rose by 8% QoQ but it fell by 6% YoY
The price to sales (P/S) is 72% lower than the 5-year quarterly average of 0.6 and 43% lower than the last 4 quarters average of 0.3
The revenue has increased by 9% year-on-year
Efficiency
How efficient is Bausch Health Companies business performance
The ROA has soared by 88% YoY
BHC's return on invested capital has surged by 54% year-on-year
BHC's return on sales is up by 37% year-on-year
Dividends
What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BHC.
Financial health
How did Bausch Health Companies financials performed over time
The current ratio has soared by 57% from the previous quarter and by 11% YoY
Bausch Health Companies's quick ratio has soared by 55% from the previous quarter and by 19% YoY
The debt to equity is up by 8% year-on-year but it has declined by 8% since the previous quarter
The company's equity rose by 8% QoQ but it fell by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.